LaunchCyte
3
16M
1
0.14
0.67
- Stages of investment
- Areas of investment
Summary
LaunchCyte appeared to be the Corporate Investor, which was created in 2000. The main office of represented Corporate Investor is situated in the Pittsburgh. The venture was found in North America in United States.
The current fund was established by Babs Carryer, Tom Petzinger.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Medical, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight Knopp Biosciences LLC.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2006. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the LaunchCyte, startups are often financed by Saturn Partners, Kramer Capital Partners. The meaningful sponsors for the fund in investment in the same round are Saturn Partners, Kramer Capital Partners. In the next rounds fund is usually obtained by Saturn Partners, Kramer Capital Partners, Biogen Idec.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.14
- Follow on index
- 0.67
- Investments by industry
- Health Care (3)
- Medical (3)
- Biotechnology (3)
- Health Diagnostics (3)
- Investments by region
-
- United States (3)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Knopp Biosciences | 03 Dec 2012 | Biotechnology, Health Care, Health Diagnostics, Medical | Late Stage Venture | 30M | United States, Pennsylvania, Pittsburgh |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.